| Dr Karen A Hoerst, MD | |
|
301 S 7th Ave, Suite 210, West Reading, PA 19611-1410 | |
| (484) 628-4656 | |
| (484) 628-4657 |
| Full Name | Dr Karen A Hoerst |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 15 Years |
| Location | 301 S 7th Ave, West Reading, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437392115 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | MD449064 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Access Telecare Pllc | 7810204831 | 262 |
News Archive
People with Alzheimer's disease could benefit from earlier diagnosis if a long-term memory test combined with a brain scan were carried out, a study suggests.
Osteoporosis is a disease categorized by brittle bones and increased risk of fracture. Individuals with osteoporosis, and diseases like it, have access to a number of treatments but no permanent solution.
Researchers at the University of Eastern Finland have developed two new cell models that can open up new avenues for ocular drug discovery. The new cell models are continuously growing retinal pigment epithelial cells, which have many benefits over the models currently used by researchers and pharmaceutical companies. The models were developed by Professor Arto Urtti's Ocular Drug Delivery group at the University of Eastern Finland.
NewYork-Presbyterian Hospital is one of six centers nationally to be selected for collaboration with AstraZeneca for an ongoing series of Phase II clinical trials of various novel compounds for potential treatment of a wide variety of cancers.
In patients with high-risk coronary artery disease (CAD), an active strategy of detecting and treating asymptomatic multisite artery disease (MSAD) combined with intensive medical therapy did not improve 2-year outcomes compared to a more traditional approach of managing only symptomatic coronary and extracoronary lesions, new research shows.
› Verified 6 days ago
| Entity Name | Tele-physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730599846 PECOS PAC ID: 2567701162 Enrollment ID: O20190625002558 |
News Archive
People with Alzheimer's disease could benefit from earlier diagnosis if a long-term memory test combined with a brain scan were carried out, a study suggests.
Osteoporosis is a disease categorized by brittle bones and increased risk of fracture. Individuals with osteoporosis, and diseases like it, have access to a number of treatments but no permanent solution.
Researchers at the University of Eastern Finland have developed two new cell models that can open up new avenues for ocular drug discovery. The new cell models are continuously growing retinal pigment epithelial cells, which have many benefits over the models currently used by researchers and pharmaceutical companies. The models were developed by Professor Arto Urtti's Ocular Drug Delivery group at the University of Eastern Finland.
NewYork-Presbyterian Hospital is one of six centers nationally to be selected for collaboration with AstraZeneca for an ongoing series of Phase II clinical trials of various novel compounds for potential treatment of a wide variety of cancers.
In patients with high-risk coronary artery disease (CAD), an active strategy of detecting and treating asymptomatic multisite artery disease (MSAD) combined with intensive medical therapy did not improve 2-year outcomes compared to a more traditional approach of managing only symptomatic coronary and extracoronary lesions, new research shows.
› Verified 6 days ago
| Entity Name | Access Telecare Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013303080 PECOS PAC ID: 7810204831 Enrollment ID: O20210907002151 |
News Archive
People with Alzheimer's disease could benefit from earlier diagnosis if a long-term memory test combined with a brain scan were carried out, a study suggests.
Osteoporosis is a disease categorized by brittle bones and increased risk of fracture. Individuals with osteoporosis, and diseases like it, have access to a number of treatments but no permanent solution.
Researchers at the University of Eastern Finland have developed two new cell models that can open up new avenues for ocular drug discovery. The new cell models are continuously growing retinal pigment epithelial cells, which have many benefits over the models currently used by researchers and pharmaceutical companies. The models were developed by Professor Arto Urtti's Ocular Drug Delivery group at the University of Eastern Finland.
NewYork-Presbyterian Hospital is one of six centers nationally to be selected for collaboration with AstraZeneca for an ongoing series of Phase II clinical trials of various novel compounds for potential treatment of a wide variety of cancers.
In patients with high-risk coronary artery disease (CAD), an active strategy of detecting and treating asymptomatic multisite artery disease (MSAD) combined with intensive medical therapy did not improve 2-year outcomes compared to a more traditional approach of managing only symptomatic coronary and extracoronary lesions, new research shows.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karen A Hoerst, MD Po Box 13579, Reading, PA 19612-3579 Ph: (484) 628-0796 | Dr Karen A Hoerst, MD 301 S 7th Ave, Suite 210, West Reading, PA 19611-1410 Ph: (484) 628-4656 |
News Archive
People with Alzheimer's disease could benefit from earlier diagnosis if a long-term memory test combined with a brain scan were carried out, a study suggests.
Osteoporosis is a disease categorized by brittle bones and increased risk of fracture. Individuals with osteoporosis, and diseases like it, have access to a number of treatments but no permanent solution.
Researchers at the University of Eastern Finland have developed two new cell models that can open up new avenues for ocular drug discovery. The new cell models are continuously growing retinal pigment epithelial cells, which have many benefits over the models currently used by researchers and pharmaceutical companies. The models were developed by Professor Arto Urtti's Ocular Drug Delivery group at the University of Eastern Finland.
NewYork-Presbyterian Hospital is one of six centers nationally to be selected for collaboration with AstraZeneca for an ongoing series of Phase II clinical trials of various novel compounds for potential treatment of a wide variety of cancers.
In patients with high-risk coronary artery disease (CAD), an active strategy of detecting and treating asymptomatic multisite artery disease (MSAD) combined with intensive medical therapy did not improve 2-year outcomes compared to a more traditional approach of managing only symptomatic coronary and extracoronary lesions, new research shows.
› Verified 6 days ago
Dr. Mohammad Ali Khoshnoodi, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave Ste 210, West Reading, PA 19611 Phone: 484-628-4656 | |
Dr. John Gurski, D.O, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-9049 | |
Dr. Jayesh P Patel, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-4879 | |
Jaswin Singh, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8000 | |
Kolin Diane Good, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6th & Spruce Streets, Reading Hospital, West Reading, PA 19611 Phone: 484-628-8070 Fax: 484-628-5289 | |
Dr. Lawrence A Brzozowski, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave, 210, West Reading, PA 19611 Phone: 484-628-4656 Fax: 484-628-4657 | |
Wajihah Memon, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8000 |